Cryoport, Inc. (CYRX) financial statements and ratios from SEC XBRL: revenue $0.2B (TTM), net margin 44.4%, revenue growth 7.7% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $176.18M |
| Revenue (TTM) | $0.2B |
| Net Margin | 44.4% |
| Operating Margin (TTM) | -20.0% |
| Revenue Growth (YoY) | 7.7% |
| EPS Growth (YoY) | -109.8% |
| FCF Growth (YoY) | -31.8% |
| Price / Book | 1.77 |
| Price / Sales | 4.65 |
| FCF Yield | -2.3% |
| Altman Z-Score | 1.17 (distress) |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.7 |
CYRX overview · CYRX earnings · CYRX KPIs · CYRX documents · CYRX ownership · CYRX peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.